Status:
COMPLETED
Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Brigham and Women's Hospital
Conditions:
Endometrial Carcinoma
Cervix Cancer
Eligibility:
FEMALE
18-90 years
Brief Summary
The purpose of this study is to investigate the effect of certain variables such as the fullness of the patients bladder and the position of the treatment applicator on the dose of radiation that othe...
Detailed Description
* This study is separated into 2 phases. In phase 1, patients will be asked to have their bladder full for the second planned insertion of the brachytherapy applicator and empty for the third insertio...
Eligibility Criteria
Inclusion
- Histologic documentation of carcinoma of the uterus, post-hysterectomy stages I-IVA or vaginal cuff recurrence. Or post-hysterectomy cervix cancer stages IA or IB or post hysterectomy vaginal cancer stage I.
- ECOG performance status of less than or equal to 2
- 18 years of age or older
Exclusion
- Distant metastases
- Inoperable disease
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00165126
Start Date
January 1 2004
End Date
July 1 2008
Last Update
November 2 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115